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1. Introduction 
Viruses regulate host immune responses to propagate their progeny. Indeed, certain viruses 
successfully establish viral persistence for long periods of time even in the 
immunocompetent host. Many viruses seem to have developed clever tactics to elude, 
utilize, or suppress host innate and adaptive immune systems. Unlike the parental strain, 
the clone 13 (Cl 13) strain of lymphocytic choriomeningitis virus (LCMV) has been shown to 
persist in mice for 60 – 100 days by nullifying the function of the host immune system. 
Multiple findings obtained from this mouse model have held true in humans chronically 
infected with viruses including human immunodeficiency virus (HIV) and hepatitis viruses. 
These viruses have evolved a repertoire of mechanisms to suppress and evade the host 
immune system. By utilizing the model for the LCMV infection of mice, this review will 
focus on the viral mechanisms for inhibition or escape of host immunity, in particular the 
host dendritic cell (DC) and T cell responses. Investigating the viral strategies will help us 
better understand the virus-host interplay and design new immunotherapeutic approaches. 
1.1 The lymphocytic choriomeningitis virus model of chronic viral infection 
The Cl 13 strain of LCMV is a variant isolated from the spleens of mice infected neonatally 
with the prototypic LCMV strain, Armstrong 53b (Arm) (Ahmed, Salmi et al. 1984). Mice 
infected with LCMV Arm develop a robust acute immune response of cytotoxic T 
lymphocytes (CTLs) that rapidly clears the virus from its host (within 10 days). In contrast, 
the infection of adult mice with LCMV Cl 13 induces a profound suppression of the host 
immune system leading to viral persistence (60-100 days following the start of infection) 
(Figure 1) (Borrow, Evans et al. 1995; Sevilla, Kunz et al. 2003). The clinical importance of 
virus-induced altered or suppressed immune responses is reflected by several human virus 
infections that inhibit the immune response such as HIV and hepatitis C virus (HCV) 
(Steinman, Granelli-Piperno et al. 2003; Liu, Woltman et al. 2009). Thus, the system of LCMV 
Cl 13 infection of its natural host, the mouse, serves as an excellent model for the 
mechanistic study of virus-induced immunosuppression and for the development of novel 
targets controlling viral persistence.  
Immunosuppression caused by LCMV Cl 13 is associated with the inhibition of DC function 
and the reduced frequency and impaired activation (exhaustion) of virus-specific T cells 
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(Borrow et al. 1995; Sevilla et al. 2003; Barber, Wherry et al. 2006; Trifilo, Hahm et al. 2006). 
Exhausted T cell responses are characterized by the cells’ inability to produce antiviral and 
immune stimulatory cytokines, destroy virus-infected cells, or proliferate, and have been 
documented following multiple infections including HIV, HCV, and hepatitis B virus (Yi, 
Cox et al. 2010). 
LCMV Cl 13 differs from Arm by only two amino acids (aa); a Leu in the viral glycoprotein 
at aa 260 in Cl 13 as compared to Phe in ARM is responsible for DC infection and 
immunosuppression (Salvato, Borrow et al. 1991). LCMV Cl 13 preferentially replicates in 
the white pulp of the spleen and infects DCs in spleen and bone marrow (BM) of the mice 
via the receptor -dystroglycan (Cao, Henry et al. 1998; Smelt, Borrow et al. 2001; Sevilla et 
al. 2003). The modulation of immuno-regulatory proteins expressed on DCs was reported to 
explain the failure of DC function to stimulate or maintain T cell responses upon LCMV Cl 
13 infection. Such modulation included the downregulation of MHC molecules and co-
stimulatory proteins (Sevilla, McGavern et al. 2004), preferential production of the 
immunosuppressive cytokine, IL-10 (Brooks, Trifilo et al. 2006; Ejrnaes, Filippi et al. 2006; 
Brooks, Ha et al. 2008), and increased expression of the negative regulator, programmed 
death-ligand 1 (PD-L1) on DCs for enhanced PD-L1-PD1 interaction leading to T cell 
exhaustion (2, 11). 
 
Fig. 1. Characteristics of the different LCMV infection models. LCMV ARM infection of 
adult mice rapidly generates a strong CD8 T cell response in the host which can clear the 
virus within 10 days, while an LCMV Cl 13 infection suppresses the host immune responses 
which leads to a prolonged viral persistence lasting 60 – 100 days. 
Furthermore, following LCMV Cl 13 infection, virus-specific CD4+ T cells were functionally 
dysregulated, which contributes to the inability to sustain CTL function and facilitates viral 
persistence (Matloubian, Concepcion et al. 1994; Brooks, Teyton et al. 2005). Virus-specific 
CD4+ T cells were functionally inactivated early during the transition into viral persistence 
and failed to produce effector cytokines such as IL-2 and TNF-. Recently, IL-21 was 
identified as an essential component of CD4+ T cell help to sustain CD8+ T cell effector 
activity and resolve persistent infection (Elsaesser, Sauer et al. 2009; Frohlich, Kisielow et al. 
2009; Yi, Du et al. 2009). The detailed underlying molecular mechanism and intracellular 
signaling path for the virus-induced immunosuppression and viral persistence, however, 
are unclear. 
2. Chronic viral infections inhibit innate and dendritic cell responses 
It is generally thought that a robust CD8+ T cell response is responsible for clearing an acute 
LCMV infection (Byrne and Oldstone 1984; Fung-Leung, Kundig et al. 1991). However, a 
strong innate immune response is important for the generation of an effective adaptive 
response against viral infections (Jung, Kato et al. 2008; Rahman, Cui et al. 2008; Zucchini, 
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Bessou et al. 2008). Moreover, DCs are indispensible for the generation of the CD8+ effector 
T cells. The innate immune response provides stimulatory signals, such as type I interferons 
and IL-12 that promote the priming of CD8+ T cells and favor the T-helper 1 phenotype of 
CD4+ T cells. DCs are the key intermediate between the innate immune response and the 
adaptive immune response. DCs are the major professional antigen presenting cell subset 
that provides the necessary primary and secondary signals to induce the activation and 
proliferation of virus-specific CTL. A virus that can actively suppress these two responses 
has a significant advantage over the host immune system and the opportunity to establish a 
persistent infection. 
2.1 Chronic LCMV infections suppress type I interferon expression 
Type I interferons (IFN) and inflammatory cytokines are key to the initiation of anti-viral 
immune responses (Seo and Hahm 2010). Type I IFN is a family of cytokines comprised of 
IFN-ǂ, IFN-ǃ, IFN-ε, IFN-κ, and IFN-ω. These molecules have been shown to be potent 
antiviral cytokines by the deletion of the common receptor subunit (IFNAR1). Transgenic 
mice lacking IFNAR1 have been demonstrated to the lose ability to interfere with the 
replication of many different viruses (Muller, Steinhoff et al. 1994; Goodman, Zeng et al. 
2010; Kolokoltsova, Yun et al. 2010). High levels of type I IFN have been detected at early 
time points during an acute, LCMV Arm infection (Montoya, Edwards et al. 2005). Zhou et 
al. have demonstrated that this induction of type I IFN is due at least in part to the 
recognition of the LCMV RNA genome by retinoic acid-inducible gene I (RIG-I) and 
melanoma differentiation-associated gene 5 (MDA5) pathway along with toll-like receptor 
(TLR) 2 and 6 (Zhou, Kurt-Jones et al. 2005; Zhou, Cerny et al. 2010). Similarly, DCs from 
LCMV Cl 13-infected mice have also been shown to produce type I IFN at early time points 
of virus infection (Dalod, Salazar-Mather et al. 2002; Diebold, Montoya et al. 2003; Zuniga, 
Hahm et al. 2007). However, several days later, these cytokines are no longer detectable in 
the sera of LCMV Cl 13-infected mice (Martinez-Sobrido, Emonet et al. 2009), which 
suggests that the virus is actively suppressing the host type I IFN response. This observation 
was confirmed by Zuniga et al. who specifically examined the production of type I IFN by 
plasmacytoid DCs during an LCMV CL 13 infection (Zuniga, Liou et al. 2008). Plasmacytoid 
DCs (pDC) are a specialized subset of DCs that rapidly produce large amounts of type I IFN 
in response to viral infection (Asselin-Paturel and Trinchieri 2005; Delale, Paquin et al. 2005). 
In response to certain stimulation conditions, these cells have been observed to dedicate 50% 
of their cellular transcription to the production of type I IFN (Liu 2005; Lee, Lund et al. 
2007). Because of this high level of type I IFN, it is suggested that these cells play a key role 
in the orchestration of antiviral immune responses. In the case of an LCMV Cl 13 infection, 
the number of pDCs in LCMV Cl 13-infected mice was reduced by 50% compared to mice 
infected with LCMV Arm at 30 days post-infection (Zuniga et al. 2008). Moreover, the 
production of type I IFN in response to TLR9 activation was severely impaired in pDCs 
isolated from LCMV CL 13-infected mice, which suggests that the virus is severely limiting 
the potential of these cells to respond not only to LCMV, but also additional, unrelated 
pathogenic stimulation (Zuniga et al. 2008).  
Indeed, it has been shown that LCMV Cl 13 utilizes specific molecular mechanisms to 
inhibit type I IFN production by the host cells. Martinez-Sobrido et al. have shown that the 
nucleoprotein of LCMV is responsible for the blockade of the host type I IFN response 
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(Martinez-Sobrido, Zuniga et al. 2006). This inhibition of cytokine production is due to the 
interaction of the viral protein with the interferon regulatory factor-3 (IRF-3) activation 
pathway. The data demonstrated that LCMV nucleoprotein (NP) impaired the nuclear 
translocation of IRF-3, which is involved in the upregulation of type I IFN synthesis. More 
specifically, amino acid residue 382 of LCMV NP was sufficient to inhibit the host type I IFN 
response (Martinez-Sobrido et al. 2009).  
Additional studies have been carried out to investigate the mechanisms behind the 
LCMV-mediated blockade of the host type I IFN response. LCMV NP blockade of the IRF-
3 pathway also affects the response to RIG-I and MDA5 (Zhou et al. 2010). Moreover, this 
same study demonstrated that LCMV NP physically interacts with both RIG-I and MDA5. 
Mutations in LCMV NP that prevented the inhibition of type I IFN however did not affect 
this interaction, which suggests that there are additional inhibitory mechanisms (Zhou et 
al. 2010). 
This suppression of type I IFN not only affects the host response against LCMV, but it may 
also reduce the effectiveness of responses against other opportunistic pathogens whose 
clearance requires type I IFN (Zuniga et al. 2008). The effects of chronic LCMV Cl 13 
infections also lead to disruptions in the ability of the host’s pDCs to produce type I IFN in 
response to other unrelated infections such as vesicular stomatitis virus (VSV) or murine 
cytomegalovirus (MCMV). In addition, LCMV Cl 13 infection had deleterious consequences 
on the host’s natural killer cell population which may be important in the immune response 
to other viral, bacterial, or parasitic infections such as HIV, influenza virus, Mycobacterium 
tuberculosis (Vankayalapati, Garg et al. 2005), and Plasmodium falciparum (Alter, Malenfant et 
al. 2004; Byrne, McGuirk et al. 2004; Siren, Sareneva et al. 2004; Korbel, Newman et al. 2005; 
Zuniga et al. 2008). Pre-infection with LCMV Cl 13 was also demonstrated to prevent the 
host from counteracting the early spread of MCMV and therefore preventing viral clearance 
(Zuniga et al. 2008). 
2.2 Suppression of dendritic cell functions 
DCs are key mediators of adaptive immune responses. This group of cells can efficiently 
present endogenously and exogenously synthesized viral antigens to CD8+ T cells. In 
addition, these cells provide the necessary co-stimulatory signals to CTL for activation. The 
effect of chronic LCMV Cl 13 infections on the production of type I IFN by pDCs is only one 
aspect of the virus-induced restrictions of the host’s DC responses. Not only do chronically 
infecting viruses suppress cytokine production by host DCs, but it has also been shown that 
they can suppress the development of dendritic cells from hematopoietic precursor cells, 
inhibit the maturation of DCs following exposure to activation signals, and also lead to the 
destruction of these cells that are critical for effective anti-viral immune responses. 
One major mechanism that LCMV Cl 13 uses to suppress DC responses is to suppress their 
development from hematopoietic precursor cells (Hahm, Trifilo et al. 2005; Trifilo et al. 
2006). The cytokines fms-like tyrosine kinase receptor-3 ligand (Flt3-L) and granulocyte 
macrophage-colony stimulating factor (GM-CSF) are major signals in the development of 
DCs from hematopoietic stem cells and can be used to induce the differentiation of DCs both 
in vitro and in vivo (Sevilla et al. 2004; Hahm et al. 2005). When Flt3-L is administered to 
mice, it dramatically increases the number of splenic DCs (Drakes, Lu et al. 1997). When 
bone marrow is cultured in vitro with GM-CSF, the stem cells differentiate into CD11c+ 
www.intechopen.com
 
Viruses Strive to Suppress Host Immune Responses and Prolong Persistence 
 
27 
dendritic cells. It has been demonstrated that LCMV Cl 13-infected mice do not respond to 
Flt3-L treatment, suggesting that the virus induces an Flt3-L-refractory state in the 
hematopoietic precursor cells (Sevilla et al. 2004; Hahm et al. 2005). Moreover, in vitro 
culture of bone marrow cells infected by LCMV Cl 13 with GM-CSF induced the 
development of significantly fewer CD11c+ DCs compared to uninfected bone marrow cells 
(Sevilla et al. 2004; Hahm et al. 2005). Collectively these data indicate that one mechanism 
that chronic LCMV infection utilizes to evade the immune system is to prevent the 
development of DCs which are critical to a successful adaptive immune response. 
Although LCMV Cl 13 does inhibit the differentiation of DCs from their hematopoietic 
progenitors, functional DCs do develop. However, the virus employs additional strategies 
to suppress the responses induced by these cells. Our laboratory and others have 
demonstrated that LCMV Cl 13 infection of DCs inhibits their ability to upregulate major 
histocompatibility complex class I (MHC-I) molecules and co-stimulatory molecules such as 
B7-2 (Figure 2A) (Sevilla et al. 2004). Moreover, the LCMV Cl 13 infection in our studies not 
only prevented the upregulation of MHC-I and B7-2 but reduced the levels of their 
expression to below baseline levels. This suppression of MHC-I and co-stimulatory molecule 
expression renders the DCs unable to efficiently prime CD8+ T cells, which are necessary to 
clear the infecting virus. Although the inhibition of type I IFN expression may be the cause 
of this downregulation, there may be additional unknown mechanisms for this 
phenomenon. Further, the infected DCs were impaired in the ability to synthesize IL-12, a 
critical cytokine for T cell stimulation, in response to TLR9 ligation (Figure 2B). The results 
also support the functional abrogation of host immunity in LCMV Cl 13-infected mice upon 
the invasion of a secondary microbe that contains TLR9 ligand components such as DNA 
viruses or bacteria.  
The final postulated mechanism for LCMV evasion of dendritic cell responses is the targeted 
killing of these cells. It has been shown that persistently infecting strains of the virus have a 
mutation in the glycoprotein that affects their tropism and increases the infectivity of DCs 
(Borrow et al. 1995; Sevilla, Kunz et al. 2000). This dendritic cell-specific infection leads to 
increased antigen load and therefore makes these cells ideal targets for activated CD8+ T 
cells. Indeed, a loss of splenic DCs has been observed in the spleens of LCMV Cl 13-infected 
mice although, the ability of these infected DCs to act as targets has not yet been confirmed. 
However, DCs are efficient antigen presenting cells and because they are preferentially 
infected during an LCMV Cl 13 infection, it has been speculated that they are targeted for 
destruction by activated CD8+ T cells (Odermatt, Eppler et al. 1991; Borrow et al. 1995). 
These multiple findings have been recapitulated when DCs were infected with human-
tropic viruses. For instance, measles virus (MV) suppressed DC generation from bone 
marrow progenitor cells under the GM-CSF or Flt3-L-supplemented culture system (Hahm 
et al. 2005). Further, MV could kill DCs or strongly inhibit the ability of DCs to stimulate 
anti-viral T cells (Hahm 2009). The decrease in the DC population was also observed in the 
bloodstream of HCV or HIV-infected patients (Donaghy, Pozniak et al. 2001; Pacanowski, 
Kahi et al. 2001; Kanto and Hayashi 2004; Kanto, Inoue et al. 2004; Siavoshian, Abraham et 
al. 2005). Functional abrogation of professional antigen presenting DCs has been reported in 
multiple cases of patients who were chronically infected with pathogenic viruses. 
Like the inhibition of type I IFN, DCs have been shown to play a key role in the host 
response and elimination of viral infections. Because of this, LCMV and other chronically  
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Fig. 2. LCMV Cl 13 suppresses DC responses. (A) Bone marrow-derived DCs were 
untreated (control, CTR), infected with LCMV Cl 13 (Cl 13), or treated with loxoribine (TLR7 
ligand, 0.5mM). DCs were analyzed for the expression levels of MHC-I and B7-2 by flow 
cytometry on the following day. Mean fluorescent intensities (MFIs) for each molecule are 
shown. (B) DCs were uninfected (CTR) or infected with LCMV Cl 13. At one day post-
infection (dpi), these cells were untreated or treated with CpG (TLR9 ligand, 200 ng/ml) and 
the synthesis of IL-12 was assessed by flow cytometry.  
infecting viruses have developed multiple strategies to counteract and evade the dendritic 
cell responses. Although a great deal of effort has been focused on these evasion tactics, the 
underlying mechanisms that the viruses use to suppress these responses are still not yet 
fully elucidated.  
3. Virus-mediated T cell exhaustion 
CD8+ Cytotoxic T lymphocytes (CTLs) are a critical line of defense against viral 
infections. These cells are responsible for the recognition and subsequent killing of virus-
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infected cells. During an acute virus infection, CTLs recognize antigenic peptides 
displayed on the surface of professional antigen presenting cells (Carbone, Moore et al. 
1988). This recognition, along with co-stimulatory signals activate the CTLs to proliferate 
and gives them license to kill virus infected cells through their effector functions 
including the release of the cytotoxic molecules perforin and granzyme B (Lancki, Hsieh 
et al. 1991). In addition, activated CTLs also upregulate inflammatory cytokines including 
IFN-Ǆ and TNF-ǂ (Murray, Lee et al. 1990; Martin, Vallbracht et al. 1991; Brehm, Daniels 
et al. 2005). Following the resolution of the infection this large population of effector CTLs 
contracts into a small pool of memory cells which are able to quickly respond to 
subsequent infections by the same pathogen.  
Because CTLs are able to eliminate replicative reservoirs, persisting viruses have evolved 
methods for the evasion of these immune responses. Although the suppression of CTL 
responses begins with the disruption of dendritic cell responses as described previously, 
persistently infecting viruses such as LCMV and HIV have developed several mechanisms 
to specifically perturb CTL responses. The first method involves the exhaustion of CTLs in 
which the cells lose their ability to kill infected cells, while the other involves the modulation 
of dominant CTL epitopes, allowing the virus to escape immune recognition. These escape 
mechanisms give the viruses an additional advantage over the host immune system and 
allow for chronic viral infections. 
3.1 Exhaustion of CD8+ T cells by LCMV Cl 13 
3.1.1 Exhaustion of cytotoxic CD8+ T lymphocytes during chronic viral infection 
Exhaustion of CTL has been described in multiple viral infections including both LCMV and 
HIV as the loss of effector functions by antigen-specific CD8+ T cells. The presence of both 
acutely-infecting and chronically-infecting strains of LCMV have made this virus an 
outstanding model for determining both the effects of the virus on CTLs as well as the 
mechanism by which the virus induces T cell exhaustion. During a chronic LCMV infection, 
the virus-specific CD8+ T cell response is activated and peaks similar to an acute viral 
infection (Figure 3). However, instead of clearing the virus, the CTLs lose effector functions 
(Figure 3). The loss of CTL functionality occurs in a stepwise manner. Individual effector 
functions are lost at distinct time points over the course of the infection (Wherry, Blattman et 
al. 2003). Initially, the CTLs lose the ability to proliferate and produce IL-2 in the case of 
most chronic viral infections (Wherry et al. 2003). As the infection continues, the CTLs 
become dysfunctional in their ability to produce and secrete the inflammatory cytokine 
TNF-ǂ (Sakuishi, Apetoh et al. 2010). At later time points of the persistent infection, the cells 
also fail to produce IFN-Ǆ and lose their cytotoxic potential (Wherry et al. 2003; Jin, 
Anderson et al. 2010). In certain cases, the end result of T cell exhaustion is the death of T 
cells which leads to the reduction of the total virus-specific T cell population. The 
culmination of these dysfunctions is the inability of antigen-specific CTLs to kill virus 
infected cells, thereby allowing the virus to persist. The mechanisms LCMV Cl 13 uses to 
exhaust CTLs are not yet fully understood. It is known however that the virus activates 
inhibitory molecules that are involved in the regulation of normal immune responses to 
exhaust CTLs.  
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Fig. 3. CD8 T cell response to acute and persistent LCMV infections over time. In response to 
an acute LCMV infection (ARM, blue line), CD8 T cells rapidly expand until approximately 
day 7.  Following this expansion, the cells contract leaving a small population of memory 
cells.  During a chronic infection (Cl 13, red line), CD8 T cells expand in a similar fashion 
however quickly lose effector functions (dotted red line) and leave only a small population 
of functional CTL that are unable to resolve the infection (solid red line). 
3.1.2 Inhibitory receptors involved in T cell exhaustion 
The inhibitory receptor programmed death – 1 (PD-1) is the most extensively characterized 
molecule associated with LCMV Cl 13-mediated T cell exhaustion (Wherry, Ha et al. 2007; 
Blackburn, Shin et al. 2009; Jin et al. 2010; Vezys, Penaloza-MacMaster et al. 2011). PD-1 is a 
negative immuno-regulatory molecule in the CD28/CTLA-4 family that is expressed on the 
surface of activated CD8+ T cells. PD-1 has two ligands, PD-L1 and PD-L2 which could be 
upregulated on the surface of activated DCs and macrophages, although PD-L1 is expressed 
on multiple cell types (Yamazaki, Akiba et al. 2002; Brown, Dorfman et al. 2003). The 
expression of this inhibitory receptor has been directly linked to type I IFN production 
(Terawaki, Chikuma et al. 2011). The role of the PD-1 activation in non-persistent viral 
infections is the attenuation of T cell responses to prevent unnecessary immunopathology 
(Freeman, Long et al. 2000). PD-1 is thought to play a critical role in the LCMV-mediated 
exhaustion of CTLs as virus-specific CD8+ T cells express significantly higher levels of this 
molecule during chronic LCMV infections. The mechanisms behind the LCMV-mediated 
upregulation of PD-1 have yet to be fully elucidated. However, the blockade of the PD-1 
pathway restores functionality of these cells and leads to clearance of the persistent virus 
infection (Barber et al. 2006). 
Another molecule that has been implicated in the exhaustion of CD8+ T cells during chronic 
LCMV infections is lymphocyte activated gene – 3 (LAG-3) (Wherry et al. 2007; Grosso, 
Goldberg et al. 2009). This molecule belongs to the immunoglobulin superfamily and has 
been shown to be immunomodulatory in the prevention of autoimmune disorders 
(Workman, Dugger et al. 2002). The expression of LAG-3 does not change on CD8+ T cells 
during acute infections with LCMV, but is upregulated on CD8+ T cells in LCMV Cl 13-
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infected mice (Richter, Agnellini et al. 2010). It has been suggested that LAG-3 functions in a 
similar fashion to PD-1 during chronic LCMV Cl 13 infections (Blackburn et al. 2009). 
Although mice deficient in LAG-3 do not demonstrate improved CD8+ T cell responses 
during persistent LCMV infections (Richter et al. 2010), the simultaneous blockade of both 
the PD-1 and LAG-3 pathways leads to significant improvements in the CTL responses of 
LCMV Cl 13-infected mice compared to PD-1 blockade alone (Blackburn et al. 2009).  
Multiple other immunomodulatory molecules have been suggested to be involved in the 
attenuation of virus-specific CD8+ T cell responses. An extensive study by Wherry et al. has 
shown that the expression of many different genes from multiple cellular processes is 
affected during CD8+ T cell exhaustion. These markers include natural killer cell marker 2B4 
(2B4), which has since been shown to be involved in the regulation of memory CD8+ T cells 
during chronic LCMV infections (West, Youngblood et al. 2011), T cell Ig- and mucin-
domain-containing molecule-3 (Tim-3), CD160, paired Ig-like receptor-B (PIR-B), and 
GP49B. All of these molecules have been shown to have inhibitory functions during immune 
responses (Wherry et al. 2007; Jin et al. 2010; Vezys et al. 2011). Although Tim-3 has been 
shown to act in cooperation with PD-1 in the exhaustion of CD8+ T cells during persistent 
LCMV infections (Jin et al. 2010), no specific mechanisms in the loss of function of CD8+ T 
cells have been attributed to these additional markers of T cell exhaustion. Until these 
markers are investigated individually or in conjunction with the known inhibitory 
molecules, they are only guilty by association.  
The markers and mechanisms that have been described by comparing the persistent and 
acute LCMV infections are by no means the only ones involved in the suppression of CD8+ 
T cell responses. Other immunosuppressive molecules have been shown to either be 
involved in the exhaustion of CD8+ T cell responses or upregulated on exhausted T cells in 
other persistent viral infections. CTLA-4, among the others discussed above, has been 
shown to be important in serious human infections such as HIV and HCV (Hryniewicz, 
Boasso et al. 2006; Kaufmann, Kavanagh et al. 2007; Nakamoto, Cho et al. 2009).  
3.1.3 Transcription factors involved in T cell exhaustion 
Several transcription factors have also been identified as modulators of the CD8+ T cell 
response during a persistent LCMV Cl 13 infection (Shaffer, Lin et al. 2002; Agnellini, Wolint et 
al. 2007). Nuclear factor of activated T cells (NFAT) is a transcription factor that regulates 
multiple genes involved in the cytotoxicity and inflammatory cytokine production by CD8+ T 
cells, including IL-2, the loss of which is a hallmark of T cell exhaustion (Wherry et al. 2003). 
NFAT expression and phosphorylation are unperturbed in the CD8+ T cells from mice 
persistently infected with LCMV. However, the translocation of NFAT molecules from the 
cytoplasm to the nucleus is disrupted during chronic LCMV infections which prevents the 
transcription factor from upregulating genes necessary for complete CTL function (Agnellini et 
al. 2007). The transcription factor B-lymphocyte-induced maturation protein-1 (Blimp-1) which 
is known to govern the fate decision of B-cells has also been associated with the exhaustion of 
CD8+ T cells (Shaffer et al. 2002; Calame 2006). Blimp-1 expression was shown to be 
dramatically increased in T cells during chronic viral infections (Shin, Blackburn et al. 2009). In 
this same series of experiments, a conditional knockout of Blimp-1 resulted in significant 
decreases of the inhibitory receptors PD-1 and LAG-3 in CD8+ T cells during a chronic LCMV 
Cl 13 infection. Moreover, this conditional knockout resulted in increased cytotoxicity of 
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LCMV-specific CTL and improved viral control (Shin et al. 2009). Although the research into 
these transcriptional regulators has revealed another level of immune evasion by LCMV Cl 13, 
they have not completely elucidated the pathway by which the virus induces T cell 
exhaustion. Therefore more research is still required to fully understand these mechanisms. 
3.1.4 Role of chronic antigen stimulation on T cell exhaustion 
One possible mechanism that has been postulated to be involved in the upregulation of 
these markers and the subsequent exhaustion of virus-specific CD8+ T cells is the prolonged 
presence of viral antigens. In a study by Bucks et al., repeated exposure to influenza antigen 
was shown to induce the exhaustion of antigen-specific CTLs. In these experiments, 
repeated exposure to antigen reduced both the frequency and number of virus specific 
CD8+ T cells, and significantly impeded the ability of the remaining cells to produce IFN-Ǆ 
(Bucks, Norton et al. 2009). In support of these findings, a more recent study has 
investigated the epigenetic regulation CD8+ T cells during a chronic LCMV infection 
(Youngblood, Oestreich et al. 2011). The results of this study indicate that long-term antigen 
exposure results in prolonged demethylation of the PD-1 gene locus, leading to extended 
PD-1 expression which has been observed during chronic LCMV infections. In addition, this 
demethylation does not resolve rapidly in exhausted T cells due to a downregulation of 
methyltransferases. Consequently, these exhausted CD8+ T cells have the potential for rapid 
upregulation of PD-1 upon subsequent antigen encounters (Youngblood et al. 2011).  
3.1.5 Cytokines implicated in T cell exhaustion 
Another potential inducer of CD8+ T cell exhaustion is the anti-inflammatory cytokine IL-
10. IL-10 has been shown to be a potent inhibitor of inflammatory and adaptive immune 
responses. Two different studies have implicated IL-10 in chronic viral infections (Brooks et 
al. 2006; Ejrnaes et al. 2006). In these studies it was shown that IL-10-deficient mice 
chronically infected with LCMV have higher frequencies of virus-specific CTLs and 
antibody-mediated blockade of the IL-10 receptor can restore the function of exhausted, 
virus specific CD8+ T cells (Brooks et al. 2006; Ejrnaes et al. 2006). Furthermore, the IL-10 
receptor blockade also led to accelerated viral clearance in both studies (Brooks et al. 2006; 
Ejrnaes et al. 2006). The source of the IL-10 involved in the immune suppression as well as 
the mechanisms by which IL-10 is induced is still under investigation. 
Although the inflammatory cytokine IL-21 has not been shown to be directly involved in the 
induction of T cell exhaustion, its requirement in the clearance of the virus has been clearly 
demonstrated. IL-21 is produced primarily by CD4+ T cells and has been shown to induce 
the proliferation of CD8+ cytotoxic T-lymphocytes in a fashion similar to that of IL-2 
(Kasaian, Whitters et al. 2002). Because IL-2 production is lost quickly during a chronic 
LCMV infection, it is thought that IL-21 may act in a compensatory fashion. The 
requirement of IL-21 in the clearance of LCMV CL 13 was demonstrated in IL-21 receptor-
deficient mice. These mice failed to clear the virus while the wild-type control mice had 
cleared the infection by day 60 post-infection. (Elsaesser et al. 2009). In the same study by 
Elsaesser et al., it was shown that IL-21 is produced by CD4+ T cells throughout an LCMV 
Cl 13 infection (Elsaesser et al. 2009). However, in parallel experiments by Yi et al., it was 
shown that the number of IL-21-producing CD4+ T cells is 7.8 times lower than in an acute 
LCMV infection. Therefore, this loss of IL-21-producing, CD4+ T cells may be another 
critical factor in the rapid exhaustion of CD8+ T cells during a persistent LCMV infection.  
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The topic of T cell exhaustion is a major focus in the field of viral immunity. It is still not 
clear if the expression of these markers is due to the presence of a persisting viral infection, 
or if viruses have evolved specific mechanisms to activate these immunosuppressive 
pathways. However, multiple studies have demonstrated that the targeting of certain 
molecules relieves the suppression and allows the host CTL response to reassert control 
over the infection and accelerate viral clearance. If the mechanisms behind the virus-
mediated upregulation of these molecules and CD8+ T cell exhaustion can be determined, 
the many new targets for immune-based therapies can be designed, giving medicine a much 
needed advantage in the treatment of chronic viral infections. 
3.2 Dysfunction of CD4+ T cells during chronic LCMV infection 
CD4+ T cells have been shown to not play a major role in the clearance of an acute, LCMV 
Arm infection. Experiments conducted with mice deficient in CD4+ T cells demonstrate that 
they are able to clear the infection as efficiently as their wild-type counterparts (Matloubian 
et al. 1994). However in the case of a chronic LCMV Cl 13 infection, CD4+ T cells appear to 
play a more significant role, as depletion of CD4+ T cells prevents mice from clearing the 
virus (Matloubian et al. 1994). One of the major contributions these cells make is the 
production of IL-21, which as described above appears to be critical for viral clearance 
(Elsaesser et al. 2009; West et al. 2011). In addition, there is evidence that CD4+ T cells also 
become exhausted during an LCMV Cl 13 infection. Brooks et al. have demonstrated that 
CD4+ T cells begin to lose the ability to make inflammatory cytokines such as IFN-Ǆ and 
TNF-ǂ as well as IL-2 as early as day 9 post-infection (Brooks et al. 2005). Moreover, an 
increase in the production of the anti-inflammatory cytokine IL-10 by virus-specific CD4+ T 
cells was also observed during the chronic LCMV infection (Brooks et al. 2005). There was 
however no increase in the number of T regulatory CD4+ T cells observed during the course 
of the viral infection (Brooks et al. 2005). Similar to exhausted CD8+ T cells, exhausted CD4+ 
T cells have also been shown to upregulate the expression of PD-1 (Day, Kaufmann et al. 
2006; Kasprowicz, Schulze Zur Wiesch et al. 2008). In addition, recent evidence suggests that 
viral persistence actually reprograms the differentiation of CD4+ T cells from the T-helper 1 
phenotype to a T-follicular helper cells (Fahey, Wilson et al. 2011). 
 
System 
Targeted 
Disruption of Cellular 
Function 
Phenotype/Mechanism 
Type I 
Interferon 
Inhibition of type I IFN 
production 
LCMV NP 
- Inhibition of IRF3 
- Inhibition of MDA5 and RIG-I 
Inhibition of plasmacytoid DCs 
Dendritic 
Cells 
Inhibition of DC development Decrease in the frequency of CD11c+ cells 
Inhibition of DC maturation 
MHC-I and B7-1/B7-2 upregulation impaired 
following PAMP ligation 
Loss of IL-12 production 
Increased IL-10 synthesis 
T cells 
Suppression of T cell function 
(exhaustion) 
PD-1↑, LAG-3↑, Tim-3↑, 
Blimp-1↑, NFAT↑ 
IFN-Ǆ↓, TNF-ǂ↓, IL-2↓, 
Proliferation↓, 
Cytotoxic activity ↓ 
Table 1. Immunological Effects of Persistent LCMV Cl 13 Infections. 
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Fig. 4. Schematic representation of the immune cell phenotypes during a chronic LCMV 
infection. Viral load over time is represented by the red line. The functional T cell response 
is illustrated using the black line. Alterations in cell surface molecule and cytokine 
expression is noted with each cell type. 
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4. Perspectives 
Chronic viral infections continue to be a tremendous burden on human health. Many 
years of research, especially with LCMV Cl 13, has led to a large body of knowledge as to 
how these viruses subvert and evade both innate and adaptive immune responses (Figure 
4 and Table 1). Although there is still a great deal of research needed, several potential 
molecular immunotherapeutic treatment options have been developed through these 
studies. First, findings by Brooks et al. and Ejarnes et al. have clearly demonstrated that 
the blockade of IL-10 signaling could be used as a potential treatment to restore 
functionality to exhausted CD8+ T cells. This has been examined recently and it was 
found that CD8+ T cells from HIV positive patients could be restored using an IL-10-
specific antibody (Brockman, Kwon et al. 2009). Similarly, clinical trials are being 
conducted to evaluate a treatment consisting of inhibition of the PD-1/PD-L1 interaction 
to recover exhausted CD8+ T cells during HIV infection and certain types of cancer 
(Sakthivel, Gereke et al. 2011). Other treatment options have been explored including 
multiple therapeutic vaccination strategies such as DNA vaccines (Martins, Lau et al. 
1995), recombinant virus vectors (Wherry, Blattman et al. 2005), and lipo-peptide vaccines 
(von Herrath, Berger et al. 2000). Finally, the use of IFN-ǂ for the treatment of chronic 
virus infections was introduced in 1986 for the treatment of hepatitis C virus infections 
(Hoofnagle, Mullen et al. 1986). However, some evidence suggests that therapeutic 
vaccination post-infection may not be as effective as hoped because of the 
immunosuppressed state of the host caused by the infection (Wherry et al. 2005).  
In addition to the molecular therapies, immune cell-based therapeutic approaches have been 
developed. Since CD8+ CTLs are principal players for the eradication of viruses, the CD8+ T 
cell-based therapy has been implemented (Gottschalk, Bollard et al. 2006; Kapp, Tan et al. 
2007). However, the requirement of CD4+ T cells for the maintenance of CTL activity has 
prompted the use of combined T cell therapies. Further, owing to the extraordinary ability 
of DCs to serve as natural adjuvants, the potential of antigen-mounted, activated DCs for 
the treatment of infectious diseases has been confirmed in multiple experimental models 
(Inaba, Metlay et al. 1990; Fajardo-Moser, Berzel et al. 2008). If DCs are suppressed by 
chronic viral infections for T cell exhaustion or deletion, provision of active, modulatory 
DCs presenting viral epitopes could overcome virus-induced suppressive environments and 
initiate vigorous anti-viral T cell immunity. The proper use of DC subtypes, DC modulation 
methodology and the way to activate intracellular class I MHC antigen presenting pathways 
as well as MHC class II pathways need to be considered to maximize the efficacy of DC-
based immunocytotherapy. 
Collectively, there is a great deal of understanding the mechanisms behind LCMV-induced 
immunosuppression (Figure 4 and Table 1) that has had practical applications for serious 
chronic human viral infections and have led to clinical trials for therapeutic interventions. 
However, many of the underlying causes have yet to be determined and further 
investigations are needed. In conjunction with molecular mechanistic studies, the approach 
to subvert the immunosuppressive environment caused by chronic viral infections could aid 
the development of immune-therapeutic drugs and treatments to combat many viral 
diseases.  
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